Tides USA

TIDES USA

TIDES USA is the flagship must-attend event in the TIDES: Oligonucleotide & Peptide Therapeutics portfolio. It is the world’s largest gathering for those interested in accelerating oligonucleotide, peptide, mRNA and genome editing products from early discovery to late-stage development and commercialization.

The program features 4 concurrent tracks covering the following 6 scientific themes including in-depth development strategies, trends, and technologies across the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing.

TIDES USA 2022 TRACKS:

  1. Oligonucleotide Chemistry, Manufacturing & Controls
  2. Oligonucleotide Discovery, Preclinical and Clinical
  3. Peptide Chemistry, Manufacturing & Controls
  4. Peptide Discovery, Preclinical and Clinical
  5. mRNA Therapeutics/Vaccines & Genome Editing
  6. Drug Delivery Innovations
Hzymes Biotechnology

Founded in 2015, Hzymes Biotechnology Co., Ltd. (Enzymes) is a high-tech enterprise specializing in the research and development, production, application and technical services of enzymes.

Wuhan Glycogene Pharmaceutical Co., Ltd.
Wuhan Glycogene Pharmaceutical Co., Ltd. is an international biotechnology enterprise focusing on the R&D and production of nucleosides, nucleotides, phosphoramidite monomers and sugar-related products.

Contact

Hzymes Biotechnology Co., Ltd

Wuhan Glycogene Pharmaceutical Co., Ltd.